Table 3.
Factors associated with statin prescription among HIV-infected persons and matched controls in the study cohort.
| HIV infected |
Controls |
|||
|---|---|---|---|---|
| Unadjusted OR (95% CI)a |
Adjusted OR (95% CI)a,b |
Unadjusted OR (95% CI)a |
Adjusted OR (95% CI)a,b |
|
| Age (per 10 years) |
1.90
(1.49–2.41) |
n/a |
2.01
(1.57–2.57) |
n/a |
| Male sex | 1.26 (0.79–1.99) |
n/a |
1.74
(1.14–2.64) |
n/a |
| Race | ||||
| White | 1.00 (Ref) | n/a | 1.00 (Ref) | n/a |
| Non-White |
0.56
(0.39–0.81) |
n/a |
0.84
(0.61–1.18) |
n/a |
| Insurance | ||||
| Public | 1.25 (0.86–1.81) |
0.94 (0.53–1.63) |
1.03 (0.74–1.43) |
0.75 (0.44–1.23) |
| Private |
0.66
(0.46–0.97) |
0.53
(0.30–0.97) |
0.83 (0.59–1.16) |
0.73 (0.43–1.24) |
| None | 1.35 (0.84–2.16) |
1.38 (0.81–2.32) |
1.28 (0.84–1.94) |
1.36 (0.83–2.20) |
| Tobacco use | 0.78 (0.53–1.14) |
0.92 (0.60–1.40) |
0.97 (0.74–1.43) |
0.91 (0.62–1.36) |
| Cocaine use |
0.39
(0.18–0.83) |
0.62 (0.28–1.36) |
0.99 (0.64–1.54) |
1.11 (0.65–1.90) |
| Diabetes |
3.05
(1.73–5.39) |
3.08
(1.62–5.89) |
6.27
(4.31–9.13) |
7.30
(4.72–11.3) |
| Mean SBP (per 10 mmHg) |
0.97 (0.84–1.12) |
0.93 (0.79–1.10) |
1.21 (1.08–1.35) |
1.12 (0.99–1.29) |
| Mean total cholesterol (per 10 mg/dL) |
1.08
(1.04–1.12) |
1.05 (0.99–1.10) |
1.01 (0.98–1.04) |
0.99 (0.94–1.06) |
| Mean LDL cholesterol (per 10 mg/dL) |
1.15
(1.09–1.21) |
1.11
(1.02–1.20) |
1.05 (1.00–1.10) |
1.12
(1.03–1.22) |
| Mean HDL Cholesterol (per 10 mg/dL) |
0.96 (0.86–1.07) |
0.94 (0.82–1.06) |
0.74
(0.65–0.85) |
0.77
(0.66–0.89) |
Note: Bold, meets statistical significance at p-value < 0.05.
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; n/ a, not applicable; OR, odds ratio; ref, reference.
a
Logistic regression.
b
Adjusting for all relevant clinical risk factors discussed in text.